Watts Ryan J. 4
4 · Denali Therapeutics Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-01-03+54,180→ 289,987 total - Award
Stock Option (right to buy)
2025-01-03+162,540→ 162,540 totalExercise: $21.26Exp: 2035-01-02→ Common Stock (162,540 underlying)
Holdings
- 2,202,604(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2026 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
- [F2]Includes 192,940 Unvested RSUs.
- [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- [F4]25% of the shares subject to the option shall vest on January 3, 2026, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.